The identification of proteins that suppress T cell responses such as Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed death-ligand 1 (PD-1) and its ligand PD-L1 opens up new opportunities for treating certain cancers having elevated production of such proteins. Here, CD274 is linked to cancer.